Salud financiera de hoja de balance de Sinopharm Tech Holdings
Salud financiera controles de criterios 0/6
Sinopharm Tech Holdings has a total shareholder equity of HK$-182.5M and total debt of HK$10.0M, which brings its debt-to-equity ratio to -5.5%. Its total assets and total liabilities are HK$46.2M and HK$228.7M respectively.
Información clave
-5.5%
Ratio deuda-patrimonio
HK$10.00m
Deuda
| Ratio de cobertura de intereses | n/a |
| Efectivo | HK$8.51m |
| Patrimonio | -HK$182.51m |
| Total pasivo | HK$228.74m |
| Activos totales | HK$46.23m |
Actualizaciones recientes sobre salud financiera
No hay actualizaciones
Recent updates
Is Sinopharm Tech Holdings Limited's (HKG:8156) Shareholder Ownership Skewed Towards Insiders?
Feb 02
How Much Did Sinopharm Tech Holdings'(HKG:8156) Shareholders Earn From Share Price Movements Over The Last Five Years?
Dec 29
How Should Investors Feel About Sinopharm Tech Holdings' (HKG:8156) CEO Remuneration?
Nov 24Análisis de la situación financiera
Pasivos a corto plazo: 8156 has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.
Pasivo a largo plazo: 8156 has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.
Historial y análisis de deuda-patrimonio
Nivel de deuda: 8156 has negative shareholder equity, which is a more serious situation than a high debt level.
Reducción de la deuda: 8156's has negative shareholder equity, so we do not need to check if its debt has reduced over time.
Hoja de balance
Análisis de cash runway
En el caso de las empresas que de media han sido deficitarias en el pasado, evaluamos si tienen al menos 1 año de cash runway.
Cash runway estable: Insufficient data to determine if 8156 has enough cash runway based on its current free cash flow.
Pronóstico de cash runway: Insufficient data to determine if 8156 has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.